Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Non Operating Income: 2023-2024

Historic Non Operating Income for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $2.0 billion.

  • Inhibrx Biosciences' Non Operating Income fell 149.23% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 100.05%. This contributed to the annual value of $2.0 billion for FY2024, which is 9947.45% up from last year.
  • According to the latest figures from FY2024, Inhibrx Biosciences' Non Operating Income is $2.0 billion, which was up 9,947.45% from -$20.5 million recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Non Operating Income peaked at $2.0 billion during FY2024, and registered a low of -$20.5 million during FY2023.
  • Moreover, its 2-year median value for Non Operating Income was $999.3 million (2023), whereas its average is $999.3 million.
  • Data for Inhibrx Biosciences' Non Operating Income shows a peak YoY spiked of 9,947.45% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Non Operating Income stood at -$20.5 million in 2023, then soared by 9,947.45% to $2.0 billion in 2024.